Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

John Brown Miller, M.D.

Co-Author

This page shows the publications co-authored by John Miller and Joan Miller.
Connection Strength

5.453
  1. Wide-field swept-source optical coherence tomography angiography in the assessment of retinal microvasculature and choroidal thickness in patients with myopia. Br J Ophthalmol. 2021 Aug 12.
    View in: PubMed
    Score: 0.247
  2. Age-Related Macular Degeneration (AMD): A View to the Future. J Clin Med. 2021 Mar 08; 10(5).
    View in: PubMed
    Score: 0.239
  3. Widefield Swept-Source OCT Angiography Metrics Associated with the Development of Diabetic Vitreous Hemorrhage: A Prospective Study. Ophthalmology. 2021 Sep; 128(9):1312-1324.
    View in: PubMed
    Score: 0.239
  4. Contrast sensitivity function in patients with macular disease and good visual acuity. Br J Ophthalmol. 2021 Feb 03.
    View in: PubMed
    Score: 0.238
  5. Retinal applications of swept source optical coherence tomography (OCT) and optical coherence tomography angiography (OCTA). Prog Retin Eye Res. 2021 Sep; 84:100951.
    View in: PubMed
    Score: 0.238
  6. Detection of neovascularisation in the vitreoretinal interface slab using widefield swept-source optical coherence tomography angiography in diabetic retinopathy. Br J Ophthalmol. 2020 Dec 21.
    View in: PubMed
    Score: 0.236
  7. A quantitative comparison of four optical coherence tomography angiography devices in healthy eyes. Graefes Arch Clin Exp Ophthalmol. 2021 Jun; 259(6):1493-1501.
    View in: PubMed
    Score: 0.232
  8. Comparison of widefield swept-source optical coherence tomography angiography with ultra-widefield colour fundus photography and fluorescein angiography for detection of lesions in diabetic retinopathy. Br J Ophthalmol. 2021 04; 105(4):577-581.
    View in: PubMed
    Score: 0.228
  9. Subthreshold Exudative Choroidal Neovascularization Associated With Age-Related Macular Degeneration Identified by Optical Coherence Tomography Angiography. J Vitreoretin Dis. 2020 Oct; 4(5):377-385.
    View in: PubMed
    Score: 0.225
  10. Different Scan Protocols Affect the Detection Rates of Diabetic Retinopathy Lesions by Wide-Field Swept-Source Optical Coherence Tomography Angiography. Am J Ophthalmol. 2020 07; 215:72-80.
    View in: PubMed
    Score: 0.224
  11. Imaging Artifacts and Segmentation Errors With Wide-Field Swept-Source Optical Coherence Tomography Angiography in Diabetic Retinopathy. Transl Vis Sci Technol. 2019 Nov; 8(6):18.
    View in: PubMed
    Score: 0.218
  12. Quantitative Comparison Of Microvascular Metrics On Three Optical Coherence Tomography Angiography Devices In Chorioretinal Disease. Clin Ophthalmol. 2019; 13:2063-2069.
    View in: PubMed
    Score: 0.217
  13. Microperimetry in age-related macular degeneration: association with macular morphology assessed by optical coherence tomography. Br J Ophthalmol. 2019 12; 103(12):1769-1776.
    View in: PubMed
    Score: 0.207
  14. Choroidal thickness and vascular density in macular telangiectasia type 2 using enface swept-source optical coherence tomography. Br J Ophthalmol. 2019 11; 103(11):1584-1589.
    View in: PubMed
    Score: 0.206
  15. Visualization of Choriocapillaris and Choroidal Vasculature in Healthy Eyes With En Face Swept-Source Optical Coherence Tomography Versus Angiography. Transl Vis Sci Technol. 2018 Nov; 7(6):25.
    View in: PubMed
    Score: 0.205
  16. Imaging the Deep Choroidal Vasculature Using Spectral Domain and Swept Source Optical Coherence Tomography Angiography. J Vitreoretin Dis. 2018 May-Jun; 2(3):146-154.
    View in: PubMed
    Score: 0.196
  17. Evaluation of choroidal lesions with swept-source optical coherence tomography. Br J Ophthalmol. 2019 01; 103(1):88-93.
    View in: PubMed
    Score: 0.195
  18. CHOROIDAL THICKNESS IN DIABETIC RETINOPATHY ASSESSED WITH SWEPT-SOURCE OPTICAL COHERENCE TOMOGRAPHY. Retina. 2018 Jan; 38(1):173-182.
    View in: PubMed
    Score: 0.192
  19. Novel grid combined with peripheral distortion correction for ultra-widefield image grading of age-related macular degeneration. Clin Ophthalmol. 2017; 11:1967-1974.
    View in: PubMed
    Score: 0.190
  20. Diabetic Choroidopathy: Choroidal Vascular Density and Volume in Diabetic Retinopathy With Swept-Source Optical Coherence Tomography. Am J Ophthalmol. 2017 Dec; 184:75-83.
    View in: PubMed
    Score: 0.189
  21. Choroidal Changes Associated With Subretinal Drusenoid Deposits in Age-related Macular Degeneration Using Swept-source Optical Coherence Tomography. Am J Ophthalmol. 2017 Aug; 180:55-63.
    View in: PubMed
    Score: 0.184
  22. BASELINE PREDICTORS ASSOCIATED WITH 3-YEAR CHANGES IN DARK ADAPTATION IN AGE-RELATED MACULAR DEGENERATION. Retina. 2021 Oct 01; 41(10):2098-2105.
    View in: PubMed
    Score: 0.062
  23. Area under the dark adaptation curve as a reliable alternate measure of dark adaptation response. Br J Ophthalmol. 2021 Apr 22.
    View in: PubMed
    Score: 0.060
  24. Association of Human Plasma Metabolomics with Delayed Dark Adaptation in Age-Related Macular Degeneration. Metabolites. 2021 Mar 21; 11(3).
    View in: PubMed
    Score: 0.060
  25. Genomic-Metabolomic Associations Support the Role of LIPC and Glycerophospholipids in Age-Related Macular Degeneration. Ophthalmol Sci. 2021 Mar; 1(1).
    View in: PubMed
    Score: 0.060
  26. Higher Intake of Polyunsaturated Fatty Acid and Monounsaturated Fatty Acid is Inversely Associated With AMD. Invest Ophthalmol Vis Sci. 2020 02 07; 61(2):20.
    View in: PubMed
    Score: 0.055
  27. Validation of RetmarkerAMD as a semiautomatic grading software for AMD. Eye (Lond). 2020 03; 34(3):600-602.
    View in: PubMed
    Score: 0.054
  28. Human Plasma Metabolomics in Age-Related Macular Degeneration: Meta-Analysis of Two Cohorts. Metabolites. 2019 Jul 02; 9(7).
    View in: PubMed
    Score: 0.053
  29. Urine Nuclear Magnetic Resonance (NMR) Metabolomics in Age-Related Macular Degeneration. J Proteome Res. 2019 03 01; 18(3):1278-1288.
    View in: PubMed
    Score: 0.052
  30. Reply. Ophthalmology. 2018 07; 125(7):e46-e47.
    View in: PubMed
    Score: 0.050
  31. HEALTH CONDITIONS LINKED TO AGE-RELATED MACULAR DEGENERATION ASSOCIATED WITH DARK ADAPTATION. Retina. 2018 Jun; 38(6):1145-1155.
    View in: PubMed
    Score: 0.049
  32. Peripheral Changes Associated With Delayed Dark Adaptation in Age-related Macular Degeneration. Am J Ophthalmol. 2018 06; 190:113-124.
    View in: PubMed
    Score: 0.049
  33. Human Plasma Metabolomics Study across All Stages of Age-Related Macular Degeneration Identifies Potential Lipid Biomarkers. Ophthalmology. 2018 02; 125(2):245-254.
    View in: PubMed
    Score: 0.047
  34. Human plasma metabolomics in age-related macular degeneration (AMD) using nuclear magnetic resonance spectroscopy. PLoS One. 2017; 12(5):e0177749.
    View in: PubMed
    Score: 0.046
  35. Structural Changes Associated with Delayed Dark Adaptation in Age-Related Macular Degeneration. Ophthalmology. 2017 09; 124(9):1340-1352.
    View in: PubMed
    Score: 0.046
  36. Automated Brightness and Contrast Adjustment of Color Fundus Photographs for the Grading of Age-Related Macular Degeneration. Transl Vis Sci Technol. 2017 Mar; 6(2):3.
    View in: PubMed
    Score: 0.045
  37. miR-17-3p Exacerbates Oxidative Damage in Human Retinal Pigment Epithelial Cells. PLoS One. 2016; 11(8):e0160887.
    View in: PubMed
    Score: 0.044
  38. Mitochondrial DNA has a pro-inflammatory role in AMD. Biochim Biophys Acta. 2015 Nov; 1853(11 Pt A):2897-906.
    View in: PubMed
    Score: 0.041
  39. Conversion to aflibercept for chronic refractory or recurrent neovascular age-related macular degeneration. Am J Ophthalmol. 2013 Jul; 156(1):29-35.e2.
    View in: PubMed
    Score: 0.035
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.